Approaching a damages calculation on a cross-undertaking

AstraZeneca AB & Anor v KRKA, d.d Novo Mesto and Consilient Health Ltd [2014] EWHC 84 (Pat) relates to an application for payment of damages, further to a cross-undertaking on a preliminary injunction. The preliminary injunction in question had been ordered against Consilient in 2010, preventing it from marketing its own-brand proton pump inhibitor (PPI), Emozul. The injunction was obtained on the basis of the patent protecting AstraZeneca’s PPI product, Nexium.

However, AstraZeneca later lost a related infringement action against Ranbaxy on this patent and, as a result, concluded that it could not win at trial against Consilient. Hence, AstraZeneca applied to have the injunction discharged…

Click on the link below to read the rest of the Taylor Wessing briefing.

Briefings from Taylor Wessing

View more briefings from Taylor Wessing

Analysis from The Lawyer

  • merger deal

    Corporate crunch time: who will triumph at The Lawyer Awards 2014?

    As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014. 

  • singapore orchid

    Singapore: Cash course

    The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world

View more analysis from The Lawyer


5 New Street Square

Turnover (£m): 228.00
No. of lawyers: 860
Jurisdiction: UK
No. of offices: 4
No. of qualified lawyers: 67 (International 50)